SplitApr 27, 2026, 09:16 AM
JAGX Granted Nasdaq Extension to May 15; 1-for-35 Reverse Split
AI Summary
Jaguar Health, Inc. received an extension from the Nasdaq Hearings Panel until May 15, 2026, to demonstrate compliance with the $1.00 bid price rule for continued listing. To meet this condition, the company announced a 1-for-35 reverse stock split of its common stock, effective April 30, 2026. Shares will begin trading on a split-adjusted basis on the effective date, aiming to achieve the required minimum bid price.
Key Highlights
- Nasdaq granted extension until May 15, 2026, to comply with $1.00 bid price rule.
- Company must report closing bid price of at least $1.00 for 10 consecutive business days by May 15, 2026.
- Jaguar Health will effect a 1-for-35 reverse stock split of its common stock.
- Reverse stock split effective on Thursday, April 30, 2026.
- Shares will begin trading on a split-adjusted basis on April 30, 2026.
- Stockholders will receive cash payment in lieu of fractional shares.